Medical Care Technologies Inc. Outlines Operating Focus With Growing Software and Subsidiary Revenue Activity Ahead of Q3 Results
Medical Care Technologies Inc. (MDCE) reported its focus on AI-driven software and subsidiaries ahead of Q3 results. The company has a $250,000 software agreement, enterprise consulting, and revenue from Infinite Auctions and Real Game Used. 2025 revenue was $1.07M with net income of $230,768. Q3 2026 results are expected to show the strongest quarterly revenue of the past year, according to the company.
How this was made
The 30-second read
Why it matters
The company signals modest revenue growth and capital‑raising plans, but the scale is limited and the stock is thinly traded.
Market read
Primary relevance is to investors in the micro‑cap/AI niche; broader market impact is minimal.
What to watch
Potential dilution from future Reg A offerings and the lack of regulatory clearance for health imaging products.
Background
Medical Care Technologies Inc. (OTCID:MDCE) issued a press release outlining its AI‑driven software focus, a $250,000 external agreement, and a 100% increase in its Reg A offering price.
Market effects
Limited impact; micro‑cap AI software focus may interest niche AI/health tech investors.
Primarily U.S. micro‑cap market; no broader regional effect.
Low; company is very small and not widely followed.
Counterpoint
The announced $250k contract and Reg A price hike may not translate into meaningful liquidity or growth for such a tiny cap.
Key entities
- companyMedical Care Technologies Inc.
Micro‑cap AI software and health‑imaging firm issuing the release.
